Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
TCG Lifesciences Pvt. Ltd. expands its footprint to the United States with the establishment of its subsidiary TCG GreenChem Inc
Friday, February 05, 2021TCG Lifesciences Pvt Ltd a company controlled by New Yorkbased The Chatterjee Group TCG has announced the expansion of its operations in the USA with the establishment of TCG GreenChem Inc a subsidiary of TCG Lifesciences Pvt Ltd to provide CDMO serv...
Swift Biosciences Accelerates its Global Expansion in China and Asia Pacific
Friday, February 05, 2021A pioneer in the development of DNA and RNA library preparation kits for NextGeneration Sequencing NGS systems Swift Biosciences announces the addition of Bruce Zhang Director of Sales and Marketing APAC to its global commercial team Bruce comes to...
Matrix Medical Network Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination
Thursday, February 04, 2021Matrix Medical Network Matrix today announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US for AZD AstraZenecas longacting monoclonal antibody LAAB combination for the potential prevention...
Engrail Therapeutics acquires NeuroCycle Therapeutics to improve and optimize drugs to improve the lives of patients with central nervous system diseases
Thursday, February 04, 2021Engrail Therapeutics announced the acquisition of the biomedical company NeuroCycle Therapeutics which is committed to the development of the inhibitory neurotransmitter GABA that exists in the human brain
Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure
Wednesday, February 03, 2021Gilead Sciences Inc and Gritstone Oncology Inc a clinicalstage biotechnology company developing next generation cancer and infectious disease immunotherapiesannounced that the companies have entered into a collaboration
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries
Wednesday, February 03, 2021Ribon Therapeutics a clinical stage oncology company developing therapeutics targeting stress support pathways announced it has entered into an exclusive license agreement with Ono Pharmaceutical Co Ltd for the development and commercialization of RB...
Evozyne Announces a Strategic Collaboration for Development of Novel Biopharmaceutical Therapeutics
Tuesday, February 02, 2021Evozyne LLC a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences announced the signing of a strategic collaboration with a leading company in rare disorders for the development and commercial...
ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
Tuesday, February 02, 2021ZebiAI Inc a biotech company focused on improving human health by powering machine learning ML to source novel targets and discover new therapeutics today announced a strategic collaboration agreement with TB Alliance a notforprofit organization dedi...
Phase 1 Drug Candidate GLR2007, Developed by Gan & Lee, Received Fast Track Designation from the US FDA
Monday, February 01, 2021Gan Lee Pharmaceuticals Co an international biopharmaceutical companyannounced that the Food and Drug Administration FDA has granted GLR Fast Track designation for the treatment of patients with glioblastoma
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
Saturday, January 30, 2021Rigel Pharmaceuticals Inc announced it has been awarded million by the US Department of Defenses DOD Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense JPEOCBRND
